MedTrace Logo

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

NCT06604260 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-09-19

No results posted yet for this study

Summary

Our main objective is to evaluate the feasibility of 68Ga-FAPi PET/CT in detecting intestinal fibrosis in patients with IBD. To this end, we will determine 68Ga-FAPi uptake in IBD in relation to cellular FAP expression in intestinal biopsies and resection specimens.

Conditions

  • IBD (Inflammatory Bowel Disease)
  • Crohn Disease (CD)
  • Ulcerative Colitis (UC)

Interventions

DIAGNOSTIC_TEST

68Ga-FAPi-46

68Ga FAPi PET-CT scan

Sponsors & Collaborators

  • Dalia Lartey

    lead OTHER

Principal Investigators

  • Mark Lowenberg, MD PhD · Amsterdam UMC

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06604260 on ClinicalTrials.gov